BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hsu CN, Tain YL. Targeting the Renin-Angiotensin-Aldosterone System to Prevent Hypertension and Kidney Disease of Developmental Origins. Int J Mol Sci 2021;22:2298. [PMID: 33669059 DOI: 10.3390/ijms22052298] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 28.0] [Reference Citation Analysis]
Number Citing Articles
1 Tain Y, Hou C, Chang-chien G, Lin S, Hsu C. Perinatal Garlic Oil Supplementation Averts Rat Offspring Hypertension Programmed by Maternal Chronic Kidney Disease. Nutrients 2022;14:4624. [DOI: 10.3390/nu14214624] [Reference Citation Analysis]
2 Tain Y, Hsu C. Metabolic Syndrome Programming and Reprogramming: Mechanistic Aspects of Oxidative Stress. Antioxidants 2022;11:2108. [DOI: 10.3390/antiox11112108] [Reference Citation Analysis]
3 Albertoni Borghese MF, Oronel LH, Ortiz MDC, Majowicz MP. Hypertension and renal disease programming: focus on the early postnatal period. Clin Sci (Lond) 2022;136:1303-39. [PMID: 36073779 DOI: 10.1042/CS20220293] [Reference Citation Analysis]
4 Huang YH, Tain YL, Hsu CN. Maternal Supplementation of Probiotics, Prebiotics or Postbiotics to Prevent Offspring Metabolic Syndrome: The Gap between Preclinical Results and Clinical Translation. Int J Mol Sci 2022;23:10173. [PMID: 36077575 DOI: 10.3390/ijms231710173] [Reference Citation Analysis]
5 Wang Y, Liu H, Ren L, Suo P, Zou L, Zhang Y, Yu X, Zhao Y. Shenkang injection improves chronic kidney disease by inhibiting multiple renin-angiotensin system genes by blocking the Wnt/β-catenin signalling pathway. Front Pharmacol 2022;13:964370. [DOI: 10.3389/fphar.2022.964370] [Reference Citation Analysis]
6 Song W, Zhou X, Duan Q, Wang Q, Li Y, Li A, Zhou W, Sun L, Qiu L, Li R, Li Y. Using random forest algorithm for glomerular and tubular injury diagnosis. Front Med (Lausanne) 2022;9:911737. [PMID: 35966858 DOI: 10.3389/fmed.2022.911737] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Tain YL, Hsu CN. Maternal High-Fat Diet and Offspring Hypertension. Int J Mol Sci 2022;23:8179. [PMID: 35897755 DOI: 10.3390/ijms23158179] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Hsu CN, Yu HR, Lin IC, Tiao MM, Huang LT, Hou CY, Chang-Chien GP, Lin S, Tain YL. Sodium Butyrate Modulates Blood Pressure and Gut Microbiota in Maternal Tryptophan-Free Diet-induced Hypertension Rat Offspring. J Nutr Biochem 2022;:109090. [PMID: 35724813 DOI: 10.1016/j.jnutbio.2022.109090] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Tain YL, Hsu CN. Novel Insights on Dietary Polyphenols for Prevention in Early-Life Origins of Hypertension: A Review Focusing on Preclinical Animal Models. Int J Mol Sci 2022;23:6620. [PMID: 35743061 DOI: 10.3390/ijms23126620] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Tain Y, Hsu C. Developmental and Early Life Origins of Hypertension: Preventive Aspects of Melatonin. Antioxidants 2022;11:924. [DOI: 10.3390/antiox11050924] [Reference Citation Analysis]
11 Hsu C, Tain Y. Chronic Kidney Disease and Gut Microbiota: What Is Their Connection in Early Life? IJMS 2022;23:3954. [DOI: 10.3390/ijms23073954] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Zeng W, Chu TTW, Ho CS, Lo CWS, Chan ASL, Kong APS, Tomlinson B, Chan SW. Lack of Effects of Renin-Angiotensin-Aldosterone System Activity and Beta-Adrenoceptor Pathway Polymorphisms on the Response to Bisoprolol in Hypertension. Front Cardiovasc Med 2022;9:842875. [DOI: 10.3389/fcvm.2022.842875] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Costa TJ, De Oliveira JC, Giachini FR, Lima VV, Tostes RC, Bomfim GF. Programming of Vascular Dysfunction by Maternal Stress: Immune System Implications. Front Physiol 2022;13:787617. [DOI: 10.3389/fphys.2022.787617] [Reference Citation Analysis]
14 Tain Y, Hsu C. Oxidative Stress-Induced Hypertension of Developmental Origins: Preventive Aspects of Antioxidant Therapy. Antioxidants 2022;11:511. [DOI: 10.3390/antiox11030511] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
15 Hsu CN, Yu HR, Chan JYH, Wu KLH, Lee WC, Tain YL. The Impact of Gut Microbiome on Maternal Fructose Intake-Induced Developmental Programming of Adult Disease. Nutrients 2022;14:1031. [PMID: 35268005 DOI: 10.3390/nu14051031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
16 Alexandrova LA, Subbotina TF, Ionova ZI, Berkovich OA, Zhloba AA. Association of plasma folic acid levels with parameters of glutathione metabolism in hypertensive patients with comorbid diseases. Arter gipertenz 2022;28:67-75. [DOI: 10.18705/1607-419x-2022-28-1-67-75] [Reference Citation Analysis]
17 Hsu CN, Tain YL. Adverse Impact of Environmental Chemicals on Developmental Origins of Kidney Disease and Hypertension. Front Endocrinol (Lausanne) 2021;12:745716. [PMID: 34721300 DOI: 10.3389/fendo.2021.745716] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
18 Hsu CN, Hou CY, Hsu WH, Tain YL. Early-Life Origins of Metabolic Syndrome: Mechanisms and Preventive Aspects. Int J Mol Sci 2021;22:11872. [PMID: 34769303 DOI: 10.3390/ijms222111872] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
19 Hsu CN, Tain YL. The First Thousand Days: Kidney Health and Beyond. Healthcare (Basel) 2021;9:1332. [PMID: 34683012 DOI: 10.3390/healthcare9101332] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
20 Okagu IU, Ndefo JC, Aham EC, Obeme-Nmom JI, Agboinghale PE, Aguchem RN, Nechi RN, Lammi C. Lupin-Derived Bioactive Peptides: Intestinal Transport, Bioavailability and Health Benefits. Nutrients 2021;13:3266. [PMID: 34579144 DOI: 10.3390/nu13093266] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]
21 Filler G, Salerno F, McIntyre CW, de Ferris MED. Animal, Human, and 23Na MRI Imaging Evidence for the Negative Impact of High Dietary Salt in Children. Curr Pediatr Rep 2021;:1-8. [PMID: 34567839 DOI: 10.1007/s40124-021-00249-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Hsu CN, Hou CY, Lee CT, Chang-Chien GP, Lin S, Tain YL. Maternal 3,3-Dimethyl-1-Butanol Therapy Protects Adult Male Rat Offspring against Hypertension Programmed by Perinatal TCDD Exposure. Nutrients 2021;13:3041. [PMID: 34578924 DOI: 10.3390/nu13093041] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
23 Tessier N, Moawad F, Amri N, Brambilla D, Martel C. Focus on the Lymphatic Route to Optimize Drug Delivery in Cardiovascular Medicine. Pharmaceutics 2021;13:1200. [PMID: 34452161 DOI: 10.3390/pharmaceutics13081200] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Hsu CN, Tain YL. Gasotransmitters for the Therapeutic Prevention of Hypertension and Kidney Disease. Int J Mol Sci 2021;22:7808. [PMID: 34360574 DOI: 10.3390/ijms22157808] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
25 Hsu CN, Hou CY, Hsu WH, Tain YL. Cardiovascular Diseases of Developmental Origins: Preventive Aspects of Gut Microbiota-Targeted Therapy. Nutrients 2021;13:2290. [PMID: 34371800 DOI: 10.3390/nu13072290] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 19.0] [Reference Citation Analysis]
26 Hsu CN, Tain YL. Animal Models for DOHaD Research: Focus on Hypertension of Developmental Origins. Biomedicines 2021;9:623. [PMID: 34072634 DOI: 10.3390/biomedicines9060623] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 18.0] [Reference Citation Analysis]
27 Hsu CN, Hou CY, Tain YL. Preventive Aspects of Early Resveratrol Supplementation in Cardiovascular and Kidney Disease of Developmental Origins. Int J Mol Sci 2021;22:4210. [PMID: 33921641 DOI: 10.3390/ijms22084210] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]